Regulation of Antioxidant Genes and Oxidative Stress

抗氧化基因和氧化应激的调节

基本信息

  • 批准号:
    8107277
  • 负责人:
  • 金额:
    $ 27.61万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2011
  • 资助国家:
    美国
  • 起止时间:
    2011-04-01 至 2015-03-31
  • 项目状态:
    已结题

项目摘要

DESCRIPTION (provided by applicant): Iron is an essential element by serving as a constituent of vital cellular proteins involved in a variety of cellular functions; however, excess iron is detrimental because it catalyzes formation of reactive oxygen species (ROS). Disorder of iron homeostasis involving iron deficiency or overload is associated with various human health problems such as neurodegenerative disease, cancer and aging. Fine-tuning of intracellular iron levels is therefore essential for maintaining normal cellular function and physiological metabolic balance. Ferritin is the major iron-storage protein in eukaryotic cells and it plays a crucial role in regulation of iron metabolism by detoxifying and storing intracellular excess iron in a non-toxic but bioavailable form. Ferritin synthesis is regulated at both transcriptional and translational levels. Translational regulatory mechanism of ferritin by iron has been extensively studied and well characterized. In contrast, iron-independent transcriptional regulation of the ferritin gene under such conditions as cells need to limit iron availability remains incompletely understood. In particular, little is known about ferritin transcriptional regulation through chromatin remodeling mechanism under oxidative stress conditions. Transcription of ferritin and a battery of antioxidant genes are regulated by a conserved enhancer, termed the ARE (antioxidant responsive element). We hypothesize that chromatin remodeling and associated factors we have recently identified on the human ferritin ARE can serve as crucial proteins that regulate ferritin transcription and iron homeostasis. The proposed experiments will focus on characterization of these new ARE-interacting proteins and their roles in chromatin modifications adjacent to ARE-regulated ferritin and antioxidant genes. The scientific impact of this research will be broad and significant because it will not only provide new insight into the basic transcriptional mechanism of a group of antioxidant genes via coordinated regulation of transcription factors and chromatin-remodeling factors, but also define new regulatory proteins responsible for cellular antioxidant response and iron homeostasis under oxidative stress conditions that are associated with various iron- and ROS-involving human diseases. PUBLIC HEALTH RELEVANCE: Oxidative stress is implicated in various disease states including cancer, neurodegeneration (such as Parkinson's and Alzheimer diseases), and aging. Cellular antioxidant genes play crucial roles in prevention and alleviation of these diseases; however, the regulatory mechanism of cellular antioxidant genes remains incompletely understood. This proposal will provide new insight into antioxidant gene regulation that is crucial for our understanding of the pathogenesis of oxidative stress related disease. In particular, disorder of iron metabolism causing iron overload is potentially toxic to the cells due to the catalytic role of iron in formation of reactive oxygen species (ROS). Thus, the tight regulation of intracellular antioxidant genes and iron levels is crucial to maintaining normal cellular function and prevention of excess ROS production and oxidative stress. This research proposal will elucidate the molecular mechanism through which oxidant- and iron-induced toxicity is alleviated in cells and tissues by investigating the regulation of major iron storage protein, ferritin. This proposal will also investigate the common regulatory mechanism of ferritin and other antioxidant genes that are involved in cellular defense mechanisms against oxidative stress.
描述(由申请人提供):铁是一种必需元素,作为参与多种细胞功能的重要细胞蛋白质的成分;然而,过量的铁是有害的,因为它催化活性氧(ROS)的形成。涉及铁缺乏或超负荷的铁稳态障碍与各种人类健康问题如神经退行性疾病、癌症和衰老相关。因此,细胞内铁水平的微调对于维持正常细胞功能和生理代谢平衡至关重要。铁蛋白是真核细胞中主要的铁储存蛋白,它通过解毒和以无毒但生物可利用的形式储存细胞内多余的铁,在调节铁代谢中发挥着至关重要的作用。铁蛋白的合成在转录和翻译水平上受到调控。铁对铁蛋白的翻译调控机制已被广泛研究和充分表征。相反,铁蛋白基因在细胞需要限制铁可用性的条件下的铁非依赖性转录调控仍然不完全清楚。特别是,很少有人知道铁蛋白转录调控通过染色质重塑机制在氧化应激条件下。铁蛋白和一系列抗氧化基因的转录受一个保守的增强子调控,称为ARE(抗氧化反应元件)。我们推测,我们最近发现的人铁蛋白ARE染色质重塑和相关因子可以作为调节铁蛋白转录和铁稳态的关键蛋白。拟议的实验将集中在这些新的ARE相互作用的蛋白质及其在染色质修饰邻近ARE调节的铁蛋白和抗氧化剂基因的作用的表征。这项研究的科学影响将是广泛和重要的,因为它不仅将通过转录因子和染色质重塑因子的协调调节为一组抗氧化基因的基本转录机制提供新的见解,而且还定义了在氧化应激条件下负责细胞抗氧化反应和铁稳态的新的调节蛋白,其与各种铁和ROS相关,涉及人类疾病。 公共卫生关系:氧化应激与各种疾病状态有关,包括癌症、神经变性(如帕金森病和阿尔茨海默病)和衰老。细胞抗氧化基因在这些疾病的预防和缓解中起着至关重要的作用,然而,细胞抗氧化基因的调控机制仍不完全清楚。这一建议将提供新的见解抗氧化基因调控,这是至关重要的,我们的氧化应激相关疾病的发病机制的理解。特别是,铁代谢紊乱导致铁过载,由于铁在活性氧(ROS)形成中的催化作用,对细胞具有潜在毒性。因此,细胞内抗氧化基因和铁水平的严格调节对于维持正常的细胞功能和防止过量的ROS产生和氧化应激至关重要。这项研究计划将通过研究主要的铁储存蛋白铁蛋白的调节,阐明氧化剂和铁诱导的毒性在细胞和组织中减轻的分子机制。这项提案还将调查铁蛋白和其他抗氧化基因的共同调控机制,参与细胞防御机制对氧化应激。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

YOSHIAKI TSUJI其他文献

YOSHIAKI TSUJI的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('YOSHIAKI TSUJI', 18)}}的其他基金

Elucidation of New Phosphorylation Site of the EWS/ATF1 Fusion Oncoprotein in Clear Cell Sarcoma
透明细胞肉瘤中 EWS/ATF1 融合癌蛋白新磷酸化位点的阐明
  • 批准号:
    10513111
  • 财政年份:
    2022
  • 资助金额:
    $ 27.61万
  • 项目类别:
Elucidation of New Phosphorylation Site of the EWS/ATF1 Fusion Oncoprotein in Clear Cell Sarcoma
透明细胞肉瘤中 EWS/ATF1 融合癌蛋白新磷酸化位点的阐明
  • 批准号:
    10670347
  • 财政年份:
    2022
  • 资助金额:
    $ 27.61万
  • 项目类别:
Regulation and Role of CREB in Cellular Genotoxic Response to Xenobiotics
CREB ​​在细胞对异生物质的基因毒性反应中的调节和作用
  • 批准号:
    8540440
  • 财政年份:
    2011
  • 资助金额:
    $ 27.61万
  • 项目类别:
Regulation and Role of CREB in Cellular Genotoxic Response to Xenobiotics
CREB ​​在细胞对异生物质的基因毒性反应中的调节和作用
  • 批准号:
    8730676
  • 财政年份:
    2011
  • 资助金额:
    $ 27.61万
  • 项目类别:
Regulation and Role of CREB in Cellular Genotoxic Response to Xenobiotics
CREB ​​在细胞对异生物质的基因毒性反应中的调节和作用
  • 批准号:
    8831225
  • 财政年份:
    2011
  • 资助金额:
    $ 27.61万
  • 项目类别:
Regulation of Antioxidant Genes and Oxidative Stress
抗氧化基因和氧化应激的调节
  • 批准号:
    8241907
  • 财政年份:
    2011
  • 资助金额:
    $ 27.61万
  • 项目类别:
Regulation of Antioxidant Genes and Oxidative Stress
抗氧化基因和氧化应激的调节
  • 批准号:
    8442949
  • 财政年份:
    2011
  • 资助金额:
    $ 27.61万
  • 项目类别:
Regulation and Role of CREB in Cellular Genotoxic Response to Xenobiotics
CREB ​​在细胞对异生物质的基因毒性反应中的调节和作用
  • 批准号:
    9114316
  • 财政年份:
    2011
  • 资助金额:
    $ 27.61万
  • 项目类别:
Regulation and Role of CREB in Cellular Genotoxic Response to Xenobiotics
CREB ​​在细胞对异生物质的基因毒性反应中的调节和作用
  • 批准号:
    8185590
  • 财政年份:
    2011
  • 资助金额:
    $ 27.61万
  • 项目类别:
Regulation and Role of CREB in Cellular Genotoxic Response to Xenobiotics
CREB ​​在细胞对异生物质的基因毒性反应中的调节和作用
  • 批准号:
    8326589
  • 财政年份:
    2011
  • 资助金额:
    $ 27.61万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了